Federal District Court Orders New York Company to Stop Distributing Adulterated and Misbranded Dietary Supplements

FDA enforcement warning letters sent to manufacturers of CBD based dietary supplements due to non-permissible misbranding and adulteration claims

FDA Warning Letters Sent to Companies That Claim Products are Effective against COVID-19

Federal Drug Administration has started sending warning letters to companies that boast their products can treat, diagnose, prevent, or cure COVID-19 or boost immunity.